Page last updated: 2024-08-22

molybdenum and trientine

molybdenum has been researched along with trientine in 25 studies

Research

Studies (25)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (4.00)	18.7374
1990's	4 (16.00)	18.2507
2000's	12 (48.00)	29.6817
2010's	8 (32.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cramarossa, L; D'Angelo, D; D'Ascanio, I; Ferri, GB; Piane, E	1
Mason, J; McQuaid, A	1
Brewer, GJ; Yuzbasiyan-Gurkan, V	1
Brewer, GJ	4
Schilsky, ML	2
Bronstein, JM; Subramanian, I; Vanek, ZF	1
Pérez-Aguilar, F	1
Brechbiel, M; Camphausen, K; Sproull, M	1
El-Youssef, M	1
Szalay, F	1
Askari, F; Brewer, GJ; Carlson, M; Dick, RB; Fink, JK; Hedera, P; Kluin, KJ; Lorincz, MT; Moretti, P; Schilsky, M; Sitterly, J; Tankanow, R	1
Medici, V; Rossaro, L; Sturniolo, GC	1
Askari, F; Brewer, GJ; Carlson, M; Dick, RB; Fink, JK; Kluin, KJ; Lorincz, MT; Sitterly, J	1
Askari, F; Brewer, GJ; Burke, JF; Dayalu, P; Lorincz, MT; Nan, B	1
Purchase, R	1
Brůha, R; Mareček, Z	1
Stremmel, W; Weiss, KH	1
Chen, C; Li, WJ; Wang, XP; Yang, RM; You, ZF	1
Alhonen, L; Hyvönen, MT; Keinänen, TA; Khomutov, AR; Khomutov, M; Pasanen, M; Peräniemi, S; Ucal, S; Vepsäläinen, J; Weisell, J	1
Członkowska, A; Litwin, T	1
Appenzeller-Herzog, C; Ewald, H; Heeres, MLS; Houwen, RHJ; Mathes, T; Weiss, KH	1

Reviews

20 review(s) available for molybdenum and trientine

Article	Year
[Wilson's disease]. Recenti progressi in medicina, 1992, Volume: 83, Issue:5 Topics: Acetates; Acetic Acid; Adult; Diagnosis, Differential; Diet; Female; Hepatolenticular Degeneration; Humans; Male; Molybdenum; Penicillamine; Pyridoxine; Sulfates; Trientine; Zinc; Zinc Sulfate	1992
Wilson's disease: an update, with emphasis on new approaches to treatment. Digestive diseases (Basel, Switzerland), 1989, Volume: 7, Issue:4 Topics: Copper; Female; Hepatolenticular Degeneration; Humans; Molybdenum; Penicillamine; Pregnancy; Trientine; Zinc	1989
Practical recommendations and new therapies for Wilson's disease. Drugs, 1995, Volume: 50, Issue:2 Topics: Chelating Agents; Copper; Female; Hepatolenticular Degeneration; Humans; Liver; Metallothionein; Molybdenum; Penicillamine; Pregnancy; Trientine; Zinc	1995
Wilson disease: genetic basis of copper toxicity and natural history. Seminars in liver disease, 1996, Volume: 16, Issue:1 Topics: Adenosine Triphosphatases; Carrier Proteins; Cation Transport Proteins; Chelating Agents; Chelation Therapy; Chromosome Mapping; Copper; Copper-Transporting ATPases; Environment; Genetic Therapy; Genome, Human; Hepatitis; Hepatolenticular Degeneration; Humans; Liver Transplantation; Molybdenum; Mutation; Penicillamine; Risk Factors; Trientine; Zinc	1996
Treatment of Wilson's disease: what are the relative roles of penicillamine, trientine, and zinc supplementation? Current gastroenterology reports, 2001, Volume: 3, Issue:1 Topics: Adenosine Triphosphatases; Chelating Agents; Drug Therapy, Combination; Female; Hepatolenticular Degeneration; Humans; Molybdenum; Penicillamine; Pregnancy; Trientine; Zinc	2001
Diagnosis and treatment of Wilson's disease. Current neurology and neuroscience reports, 2002, Volume: 2, Issue:4 Topics: Chelating Agents; Copper; Dimercaprol; Enzyme Inhibitors; Female; Hepatolenticular Degeneration; Humans; Liver Transplantation; Male; Molybdenum; Penicillamine; Trientine; Zinc	2002
[Wilson's disease: physiopathological, clinical and therapeutic considerations]. Gastroenterologia y hepatologia, 2003, Volume: 26, Issue:1 Topics: Adenosine Triphosphatases; Adolescent; Adult; Basal Ganglia Diseases; Brain; Cation Transport Proteins; Ceruloplasmin; Chelating Agents; Chelation Therapy; Copper; Copper-Transporting ATPases; Descemet Membrane; Female; Genes, Recessive; Hepatitis, Chronic; Hepatolenticular Degeneration; Humans; Liver Transplantation; Male; Mental Disorders; Middle Aged; Molybdenum; Penicillamine; Pregnancy; Pregnancy Complications; Prognosis; Recombinant Fusion Proteins; Trientine; Zinc	2003
Antiangiogenic therapy through copper chelation. Expert opinion on therapeutic targets, 2003, Volume: 7, Issue:3 Topics: Angiogenesis Inhibitors; Animals; Chelating Agents; Chelation Therapy; Copper; Corneal Neovascularization; Cyclohexylamines; Hepatolenticular Degeneration; Humans; Molybdenum; Neoplasms; Neovascularization, Pathologic; Penicillamine; Pyridines; Rabbits; Trientine	2003
Wilson disease. Mayo Clinic proceedings, 2003, Volume: 78, Issue:9 Topics: Adenosine Triphosphatases; Chelating Agents; Copper; Hepatolenticular Degeneration; Humans; Liver Transplantation; Molybdenum; Penicillamine; Trientine; Zinc	2003
[Wilson disease in 2003]. Orvosi hetilap, 2003, Dec-14, Volume: 144, Issue:50 Topics: Adenosine Triphosphatases; Cation Transport Proteins; Chelating Agents; Copper; Copper-Transporting ATPases; Diagnosis, Differential; Family Planning Services; Genetic Counseling; Genotype; Hepatolenticular Degeneration; Humans; Molybdenum; Penicillamine; Phenotype; Trientine; Zinc Acetate; Zinc Sulfate	2003
Neurologically presenting Wilson's disease: epidemiology, pathophysiology and treatment. CNS drugs, 2005, Volume: 19, Issue:3 Topics: Behavior; Chelating Agents; Enzyme Inhibitors; Hepatolenticular Degeneration; Humans; Molybdenum; Nervous System Diseases; Penicillamine; Trientine; Zinc	2005
Anticopper therapy against cancer and diseases of inflammation and fibrosis. Drug discovery today, 2005, Aug-15, Volume: 10, Issue:16 Topics: Animals; Copper; Fibrosis; Humans; Inflammation; Molybdenum; Neoplasms; Neovascularization, Pathologic; Penicillamine; Trientine	2005
Wilson disease--a practical approach to diagnosis, treatment and follow-up. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver, 2007, Volume: 39, Issue:7 Topics: Ceruloplasmin; Chelating Agents; Copper; Hepatolenticular Degeneration; Humans; Liver Transplantation; Molybdenum; Mutation; Penicillamine; Trace Elements; Treatment Outcome; Trientine; Zinc	2007
The risks of free copper in the body and the development of useful anticopper drugs. Current opinion in clinical nutrition and metabolic care, 2008, Volume: 11, Issue:6 Topics: Alzheimer Disease; Angiogenesis Inhibitors; Autoimmunity; Copper; Fibrosis; Hepatolenticular Degeneration; Humans; Inflammation; Molybdenum; Neurodegenerative Diseases; Penicillamine; Trientine	2008
The treatment of Wilson's disease, a rare genetic disorder of copper metabolism. Science progress, 2013, Volume: 96, Issue:Pt 1 Topics: Brain; Chelating Agents; Copper; Cornea; Dimercaprol; Drug Discovery; Hepatolenticular Degeneration; History, 20th Century; Humans; Liver; Molybdenum; Penicillamine; Rare Diseases; Trientine; Zinc Sulfate	2013
[Wilsons disease]. Vnitrni lekarstvi, 2013, Volume: 59, Issue:7 Topics: Adenosine Triphosphatases; Adult; Cation Transport Proteins; Chelating Agents; Copper; Copper-Transporting ATPases; Czech Republic; Female; Hepatolenticular Degeneration; Humans; Liver Cirrhosis; Liver Transplantation; Male; Molybdenum; Mutation; Penicillamine; Trientine; Zinc	2013
Clinical considerations for an effective medical therapy in Wilson's disease. Annals of the New York Academy of Sciences, 2014, Volume: 1315 Topics: Ceruloplasmin; Chelating Agents; Copper; Hepatolenticular Degeneration; Humans; Molybdenum; Penicillamine; Trientine; Zinc	2014
Current Drug Managements of Wilson's Disease: From West to East. Current neuropharmacology, 2016, Volume: 14, Issue:4 Topics: Chelating Agents; Copper; Hepatolenticular Degeneration; Humans; Medicine, Chinese Traditional; Molybdenum; Penicillamine; Succimer; Treatment Outcome; Trientine; Zinc	2016
Wilson disease - currently used anticopper therapy. Handbook of clinical neurology, 2017, Volume: 142 Topics: Chelating Agents; Copper; Enzyme Inhibitors; Hepatolenticular Degeneration; Humans; Molybdenum; Penicillamine; Prospective Studies; Trientine	2017
Comparative effectiveness of common therapies for Wilson disease: A systematic review and meta-analysis of controlled studies. Liver international : official journal of the International Association for the Study of the Liver, 2019, Volume: 39, Issue:11 Topics: Chelating Agents; Copper; Hepatolenticular Degeneration; Humans; Liver; Molybdenum; Penicillamine; Randomized Controlled Trials as Topic; Trientine; Zinc	2019

Trials

1 trial(s) available for molybdenum and trientine

Article	Year
Treatment of Wilson disease with ammonium tetrathiomolybdate: IV. Comparison of tetrathiomolybdate and trientine in a double-blind study of treatment of the neurologic presentation of Wilson disease. Archives of neurology, 2006, Volume: 63, Issue:4 Topics: Adolescent; Adult; Anemia; Chelating Agents; Copper; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Hepatolenticular Degeneration; Humans; Length of Stay; Male; Middle Aged; Molybdenum; Serum Albumin; Speech; Speech Disorders; Treatment Outcome; Trientine; Zinc	2006

Article

Year

Treatment of Wilson disease with ammonium tetrathiomolybdate: IV. Comparison of tetrathiomolybdate and trientine in a double-blind study of treatment of the neurologic presentation of Wilson disease.

Archives of neurology, 2006, Volume: 63, Issue:4

Topics: Adolescent; Adult; Anemia; Chelating Agents; Copper; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Hepatolenticular Degeneration; Humans; Length of Stay; Male; Middle Aged; Molybdenum; Serum Albumin; Speech; Speech Disorders; Treatment Outcome; Trientine; Zinc

2006

Other Studies

4 other study(ies) available for molybdenum and trientine

Article	Year
A comparison of the effects of penicillamine, trientine, and trithiomolybdate on [35S]-labeled metallothionein in vitro; implications for Wilson's disease therapy. Journal of inorganic biochemistry, 1991, Feb-01, Volume: 41, Issue:2 Topics: Animals; Copper; Cytosol; Hepatolenticular Degeneration; Liver; Male; Metallothionein; Molybdenum; Penicillamine; Rats; Rats, Inbred Strains; Sulfur Radioisotopes; Trientine	1991
Treatment of Wilson's disease with tetrathiomolybdate: V. Control of free copper by tetrathiomolybdate and a comparison with trientine. Translational research : the journal of laboratory and clinical medicine, 2009, Volume: 154, Issue:2 Topics: Chelating Agents; Clinical Trials as Topic; Copper; Double-Blind Method; Drug Administration Schedule; Hepatolenticular Degeneration; Humans; Molybdenum; Retrospective Studies; Trientine	2009
Prognostic significance of neurologic examination findings in Wilson disease. Parkinsonism & related disorders, 2011, Volume: 17, Issue:7 Topics: Adult; Chelating Agents; Dystonia; Female; Hepatolenticular Degeneration; Humans; Male; Molybdenum; Neurologic Examination; Prognosis; Risk Factors; Tremor; Trientine; Zinc	2011
Triethylenetetramine modulates polyamine and energy metabolism and inhibits cancer cell proliferation. The Biochemical journal, 2016, 05-15, Volume: 473, Issue:10 Topics: Amine Oxidase (Copper-Containing); Cell Line, Tumor; Cell Proliferation; Eflornithine; Energy Metabolism; Female; Humans; Male; MCF-7 Cells; Molybdenum; Penicillamine; Polyamines; Putrescine; Reactive Oxygen Species; Spermine; Trientine	2016